Exploring the first decade of HIV PrEP use and the persistent disparities preventing this revolutionary prevention tool from reaching everyone who needs it.
Explore the revolutionary HIV prevention drug lenacapavir, offering 99.9% protection with just two injections per year. Clinical data shows unprecedented efficacy.